We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Approval Is Fifth for BI, Lilly’s Trajenta in Type 2 Diabetes
EU Approval Is Fifth for BI, Lilly’s Trajenta in Type 2 Diabetes
August 26, 2011
The European Commission has approved Boehringer Ingelheim (BI) and Eli Lilly’s Type 2 diabetes drug Trajenta, marking the drug’s fifth positive regulatory decision.